A Case of Acneiform Skin Eruption Associated with ZD1839(Iressa(R)).
- Author:
Yong Ju KIM
1
;
Kyu Chul HWANG
;
Dong Soo YU
;
Chi Hwan OH
;
Hae Jun SONG
Author Information
1. Department of Dermatology, College of Medicine, Korea University, Seoul, Korea. hjsongMD@shinbiro.com
- Publication Type:Case Report
- Keywords:
ZD1839;
Acneiform eruption
- MeSH:
Acneiform Eruptions;
Epidermal Growth Factor;
Humans;
Keratinocytes;
Neoplasm Metastasis;
Protein-Tyrosine Kinases;
Skin*
- From:Korean Journal of Dermatology
2004;42(4):478-481
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa(R)), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa(R)).
